Adrenocortical Carcinoma (Adrenal Cortex Tumor) in Dogs

Open table of contents

When to visit the vet?

Non-urgent see a veterinarian within 2–3 days

?

If the condition worsens / symptoms persist, consult a veterinarian.

Download/Print

Definition

An adrenocortical carcinoma is a rare, malignant tumor that originates in the adrenal cortex of dogs, affecting the hormone-producing tissue of these glands.

BASICS and CAUSES:

The adrenal glands are small, triangular glands located above the kidneys. They consist of two main parts: the inner medulla and the outer cortex. The cortex is responsible for producing vital hormones such as cortisol, aldosterone, and sex hormones. These hormones regulate numerous bodily functions, including metabolism, blood pressure, and stress responses.

In adrenocortical carcinoma, cancer cells grow uncontrollably in the adrenal cortex. This can lead to overproduction or, less commonly, underproduction of these hormones, causing various health problems. The exact causes for the development of these tumors are not fully understood, but genetic factors and possibly environmental factors play a role.

Genetic predispositions might play a role in certain dog breeds, although no specific breed has been clearly identified. There are indications that chronic stress and environmental toxins could increase the risk, but further research is needed to definitively confirm these factors.

The most important facts at a glance

Adrenocortical carcinoma is a rare but aggressive tumor of the adrenal cortex in dogs, often hormonally active and clinically associated with Cushing’s syndrome. The primary therapy consists of surgical removal, which requires precise diagnosis and specialized surgical technique. In inoperable cases, medical control of hormone production can be performed. The prognosis largely depends on metastasis and resectability (how well a tumor can be surgically removed).

Causes

The exact causes are unknown, but genetic factors may play a role.

  • Hormonal Dysregulation: A malignant tumor in the adrenal cortex can lead to excessive cortisol production. Rarer variants produce aldosterone or sex hormones.
  • Genetic Factors: While there is no clearly defined breed predisposition for adrenocortical carcinomas in dogs, a familial accumulation is discussed in individual cases. In human medicine, mutations in tumor suppressor genes (e.g., TP53) are known, and their transferability to veterinary medicine is being researched.
  • Breed Prevalence: Certain dog breeds like Poodles, Dachshunds, and Beagles more frequently show Cushing’s syndrome – however, this is mostly pituitary-dependent. An adrenocortical carcinoma as a cause is possible, but overall less common.

The exact pathogenesis of adrenocortical carcinomas is not conclusively understood. Genetic factors, chronic hormonal dysregulations, and environmental carcinogens are suspected to promote their development. In human medicine, a familial accumulation within tumor syndromes has been described, but this has not yet been proven in dogs. Hormonally active carcinomas can be influenced by autocrine growth stimulation. Adrenocortical adenomas can degenerate, but a transition to a carcinoma is rarely documented. A connection with previous glucocorticoid therapy is not clearly established but is the subject of ongoing research.

Symptoms

The symptoms of an adrenocortical carcinoma can be diverse and often depend on whether the tumor is hormonally active. Owners frequently report increased thirst and urination in their dogs. This symptom is often accompanied by a changed appetite, which can be either increased or decreased.

Dogs may also show signs of Muscle weakness or wasting, especially in the hind legs. Furthermore, changes in coat or skin problems may occur, such as Hair loss and thin, sensitive skin. In some cases, dogs may also experience Weight gain or develop a bloated abdomen, which can indicate an enlarged liver or spleen.

In advanced cases or if the tumor has metastasized, general weakness, lethargy, and in some cases, neurological symptoms such as Behavioral changes or Convulsions may occur. Since the symptoms are so varied, an accurate diagnosis is crucial.

In summary:

A combination of thirst and increased urination (PU, PD) + Polyphagia (increased appetite) + skin/muscle changes suggests Cushing’s syndrome.

Diagnosis

The diagnosis of an adrenocortical carcinoma usually begins with a thorough clinical examination and a detailed medical history. Blood tests are essential to check hormone levels and rule out other possible causes of the symptoms. A special test known as the ACTH stimulation test can be used to assess adrenal gland function.

Imaging techniques such as ultrasound and computed tomography (CT) are helpful to determine the size and location of the tumor and to ascertain whether it has spread to surrounding tissue or formed metastases. An MRI may also be performed to obtain more detailed information. A biopsy may be necessary to confirm the diagnosis, especially if a malignant tumor is suspected.

In some cases, scintigraphy may be used to further evaluate adrenal gland function. These comprehensive diagnostic measures are crucial for determining the best treatment strategy.

Therapy

The primary therapy for an adrenocortical carcinoma consists of surgical removal of the tumor, if possible. The surgery can be complicated, especially if the tumor is large or has spread to surrounding tissue. In some cases, complete removal is not possible, and palliative treatment is considered.

After surgery, chemotherapy or radiation therapy may be used to combat remaining cancer cells. The choice of treatment often depends on the size of the tumor, its location, and the presence of metastases. Hormone therapies may also be used to alleviate symptoms, especially if the tumor was hormonally active.

Medications to control hormone production and alleviate symptoms can also be part of the treatment. Close monitoring of the dog through regular veterinary visits is crucial to evaluate treatment success and detect possible complications early.

Prognosis and follow-up care

The prognosis for dogs with an adrenocortical carcinoma varies greatly and depends on several factors, including the size of the tumor, the presence of metastases, and the response to treatment. If the tumor is detected early and completely removed, the prognosis can be relatively favorable.

In cases where the tumor has metastasized or cannot be completely removed, the prognosis is generally poorer. Life expectancy can then be limited to months, depending on the aggressiveness of the tumor and the chosen treatment strategy.

Early diagnosis and treatment are crucial to improve the dog’s quality of life and optimize the prognosis. Regular follow-up examinations are necessary to detect tumor recurrence or the appearance of metastases early.

Prevention

Adrenocortical carcinoma cannot be safely prevented, but early detection significantly improves the prognosis. Regular preventive examinations with blood and hormone profiles, especially in older dogs, are recommended. Symptoms such as increased drinking, Hair loss, Muscle weakness, or unusual Weight gain should be taken seriously. Avoiding unnecessary hormonal medications can reduce the risk of hormone-related changes. For genetically predisposed breeds, close monitoring is advisable. Ultrasound examinations of the abdomen can also reveal changes in the adrenal glands at an early stage.

Outlook on current research

Adrenocortical carcinoma in dogs is a rare but serious disease affecting the adrenal cortex. The adrenal cortex is responsible for producing vital hormones like cortisol. Current research investigates how genetic factors can contribute to the development of these tumors. Researchers analyze genetic markers that are more common in dogs with this disease to gain a better understanding of the causes and potential hereditary components.

Another focus of research is on improving diagnostic methods. Currently, imaging techniques such as ultrasound and CT scans are used to locate and assess tumors. New techniques under development could improve the accuracy and timeliness of diagnosis. Research into the development of biomarkers that can be detected in the blood is particularly promising, as they could potentially enable non-invasive diagnosis.

Treatment options for adrenocortical carcinomas are also an active field of research. Surgical removal of the affected adrenal glands is currently the most common form of therapy. Researchers are working to optimize surgical techniques to reduce the risk of complications and shorten recovery time. Furthermore, the effectiveness of chemotherapy and radiation therapy as complementary treatment methods is being investigated. New drugs that specifically target the molecular properties of tumor cells are also being tested in preclinical and clinical studies.

Another important aspect of research is understanding disease progression and the factors that influence survival. Long-term studies in affected dogs help to document the natural progression of the disease and assess the impact of different treatment strategies on the dogs’ quality of life. These studies provide valuable information that can help develop personalized treatment plans tailored to the individual needs of each dog.

In summary, research into adrenocortical carcinoma in dogs aims to deepen the understanding of the genetic and molecular basis of the disease, improve diagnosis and treatment options, and ultimately enhance the prognosis and quality of life for affected dogs. Advances in research could also reveal potential parallels for treating this disease in humans, which could advance knowledge and therapies in both areas.

Frequently asked questions (FAQs)

What is an adrenocortical carcinoma?
An adrenocortical carcinoma is a malignant tumor that originates in the adrenal cortex. This gland is responsible for producing important hormones, and a tumor can impair its normal function. -
What symptoms do dogs with adrenocortical carcinoma show?
Common symptoms include increased thirst and urination, Hair loss, Weight gain or loss, Muscle weakness, and Behavioral changes. These symptoms often result from the overproduction of hormones by the tumor. -
How is an adrenocortical carcinoma diagnosed?
Diagnosis is usually made through a combination of physical examination, blood tests, and ultrasound or CT scans. These tests help identify the tumor and determine its effects on the body. -
What treatment options are available for dogs with this disease?
The primary treatment is surgical removal of the affected adrenal gland. In some cases, chemotherapy or radiation therapy may be used as complementary treatments, especially if the tumor cannot be completely removed. -
What is the prognosis for dogs with adrenocortical carcinoma?
The prognosis varies depending on the size of the tumor, whether it has metastasized, and the dog's general health. Early diagnosis and treatment significantly improve survival chances. -
Can adrenocortical carcinoma be inherited in dogs?
While the exact cause is unknown, some studies suggest that genetic factors may play a role. Certain breeds appear to be more frequently affected, suggesting a possible hereditary component. -
Are certain dog breeds more susceptible to this disease?
Yes, some breeds like Poodles, German Shepherds, and Terriers seem to have a higher risk. This could be due to genetic differences that increase susceptibility to tumors. -
How can I help my dog recover after surgery?
After surgery, it is important to follow the veterinarian's instructions, which often include restricted activity, a special diet, and regular follow-up examinations. A calm and stress-free environment can also contribute to recovery. -
Are there ways to reduce the risk of adrenocortical carcinoma?
While there is no guaranteed method of prevention, a healthy diet, regular veterinary check-ups, and controlling stress factors can help reduce the overall health risk. -
How does an adrenocortical carcinoma affect my dog's quality of life?
Quality of life can be affected by symptoms such as weakness, loss of appetite, and Behavioral changes. Effective treatment aims to alleviate these symptoms and improve quality of life as much as possible.

Literature